Immunotherapy has revolutionized cancer treatment, dramatically improving survival rates of
melanoma and lung cancer patients. Nevertheless, immunotherapy is almost ineffective …

Surgical resection is the cornerstone of solid tumour treatment. Current techniques for
evaluating margin statuses, such as frozen section, imprint cytology, and intraoperative …

Photodynamic therapy (PDT) is a potential synergistic approach to chemotherapy for treating
ovarian cancer, the most lethal gynecologic malignancy. Here we used M13 bacteriophage …

Introduction: Progressive breakthroughs in nanomedicine have been instrumental for the
clinical translation of actively targeted drug-delivery approaches. Besides storing large …

As a component of p53-dependent lncRNA (long non-coding RNA), PANDAR (the promoter
of CDKN1A antisense DNA damage activated RNA) participates in the epigenetic regulation …

Our main interest is the characterization of compounds to support the development of
alternatives to currently marketed drugs that are losing effectiveness due to the development …

Long non-coding RNA plasmacytoma variant translocation 1 (PVT1) is a dysregulated gene
in malignancy and is associated with oncogenesis. In this study, we found PVT1 RNA was …

Background and purpose: Surgery is regarded as the gold standard for patients with
advanced ovarian cancer. However, complete surgical removal of tumors remains extremely …

Purpose Patients with recurrent ovarian, peritoneal, or fallopian tube cancer have limited
therapeutic options. There are no reports of nanoparticle albumin–bound paclitaxel (nab …

Often discovered at an advanced stage, ovarian cancer progresses to peritoneal carcinoma,
which corresponds to the invasion of the serosa by multiple tumor implants. The current …